Abstract
Animal models have been used widely in neurology since many decades. They have led to an improved understanding of the pathophysiological processes underlying frequent diseases as multiple sclerosis or Parkinson’s disease and enabled the development of highly effective therapeutical approaches. Current developments, drawbacks and limitations of animal models in neurology are discussed with a special focus on the experimental autoimmune encephalomyelitis – model of multiple sclerosis.
Keywords: Animal models, neurology, multiple sclerosis, encephalitogenic epitopes, experimental autoimmune encephalomyelitis, microarray, transgene animals, natalizumab, Parkinson’s disease, conditioned reflex.
Current Pharmaceutical Design
Title:Animal Models in Neurology: Drawbacks and Opportunities
Volume: 18 Issue: 29
Author(s): Robert Patejdl and Uwe K. Zettl
Affiliation:
Keywords: Animal models, neurology, multiple sclerosis, encephalitogenic epitopes, experimental autoimmune encephalomyelitis, microarray, transgene animals, natalizumab, Parkinson’s disease, conditioned reflex.
Abstract: Animal models have been used widely in neurology since many decades. They have led to an improved understanding of the pathophysiological processes underlying frequent diseases as multiple sclerosis or Parkinson’s disease and enabled the development of highly effective therapeutical approaches. Current developments, drawbacks and limitations of animal models in neurology are discussed with a special focus on the experimental autoimmune encephalomyelitis – model of multiple sclerosis.
Export Options
About this article
Cite this article as:
Patejdl Robert and K. Zettl Uwe, Animal Models in Neurology: Drawbacks and Opportunities, Current Pharmaceutical Design 2012; 18 (29) . https://dx.doi.org/10.2174/138161212802502233
DOI https://dx.doi.org/10.2174/138161212802502233 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention)
Current Neuropharmacology Neurotrophic Factors - A Tool for Therapeutic Strategies in Neurological,Neuropsychiatric and Neuroimmunological Diseases?
Current Medicinal Chemistry Functional Food: Product Development and Health Benefits
Recent Patents on Engineering Viral-Mediated Gene Transfer for Cancer Treatment
Current Pharmaceutical Biotechnology From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Current Medicinal Chemistry Conventional (Continuous) EEG Monitoring in the NICU
Current Pediatric Reviews New Opportunities in the Structure-based Design of Anti-Protozoan Agents
Current Topics in Medicinal Chemistry Brain Targeted Drug Delivery: Factors, Approaches and Patents
Recent Patents on Nanomedicine Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins
Current Gene Therapy Potential Prophylactic and Therapeutic Vaccines for HSV Infections
Current Pharmaceutical Design Gene Delivery System: A Developing Arena of Study for the New Era of Medicine
Recent Patents on DNA & Gene Sequences Editorial [ NeuroAIDS: A Neuroscience Problem with Global Impact ]
Current HIV Research Drug Target Discovery Through Analysis of Laccase Regulatory Networks of Cryptococccus neoformans
Current Enzyme Inhibition Microglia:Neuroprotective and Neurotrophic Cells in the Central Nervous System
Current Drug Targets - Cardiovascular & Hematological Disorders CCR1 and CCR2 Antagonists
Current Topics in Medicinal Chemistry Synthesis and Biological Evaluation of a Series of 4-(arylamido/imidoalkyl)- 5-(arylideno- 4-oxo-2-thio-imidazolidinyl)-N-(methyl-phenyl-imino) Acridinium Iodides as Potential Antiviral Agents
Letters in Drug Design & Discovery Caveolin-1: A Promising Therapeutic Target for Diverse Diseases
Current Molecular Pharmacology Venom Peptide Modulators of the Immune System
Inflammation & Allergy - Drug Targets (Discontinued) Encapsulation – a Convenient Way to Extend the Persistence of the Effect of Eco-Friendly Mosquito Larvicides
Current Organic Chemistry Patent Selections
Recent Patents on Anti-Cancer Drug Discovery